SJS Investment Consulting’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53K | Sell |
7
-3
| -30% | -$657 | ﹤0.01% | 660 |
|
|
2025
Q1 | $2.24K | Sell |
10
-2
| -17% | -$448 | ﹤0.01% | 676 |
|
|
2024
Q4 | $3.93K | Buy |
12
+5
| +71% | +$1.64K | ﹤0.01% | 478 |
|
|
2024
Q3 | $2.1K | Hold |
7
| – | – | ﹤0.01% | 764 |
|
|
2024
Q2 | $2.31K | Sell |
7
-1
| -13% | -$330 | ﹤0.01% | 652 |
|
|
2024
Q1 | $3.17K | Hold |
8
| – | – | ﹤0.01% | 576 |
|
|
2023
Q4 | $2.82K | Sell |
8
-2
| -20% | -$705 | ﹤0.01% | 536 |
|
|
2023
Q3 | $3.75K | Buy |
10
+1
| +11% | +$375 | ﹤0.01% | 437 |
|
|
2023
Q2 | $3.44K | Sell |
9
-1
| -10% | -$383 | ﹤0.01% | 434 |
|
|
2023
Q1 | $3.47K | Buy |
10
+2
| +25% | +$693 | ﹤0.01% | 444 |
|
|
2022
Q4 | $1.88K | Buy |
8
+5
| +167% | +$1.18K | ﹤0.01% | 657 |
|
|
2022
Q3 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 953 |
|
|
2022
Q1 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 528 |
|